Use of Transdermal Magnesium Chloride May Be Clinically Beneficial For Fibromyalgia Patients

Use of Transdermal Magnesium Chloride May Be Clinically Beneficial For Fibromyalgia Patients
Findings from a recent study published in the Journal of Integrative Medicine revealed that the use of transdermal magnesium chloride may improve scores on the Fibromyalgia Impact Questionnaire for patients with fibromyalgia. Fibromyalgia is a chronic pain syndrome with no known cause. In addition to widespread pain, patients with fibromyalgia have fatigue, depression, and sleep problems, with about 3.5% of women and 0.5% of men in the United States receiving a diagnosis of fibromyalgia. Some preliminary evidence shows that fibromyalgia is an oxidative stress disorder and deficiency in trace elements and antioxidants may have a role in the development of its associated symptoms. Magnesium is a trace element that activates almost all enzymes of the glycolytic and Krebs cycles, and is necessary for the biological synthesis of adenosine triphosphate. There is clinical evidence on the similarity between the clinical symptoms of fibromyalgia and magnesium deficiency, including the findings of tender points that indicate magnesium may be involved in fibromyalgia pathogenesis. In the study entitled “Effects of transdermal magnesium chloride on quality of life for patients with fibromyalgia: a feasibility study”, a team of researchers at the Mayo Clinic in Rochester conducted a pilot study to examine whether transdermal magn
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *